CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Your skills can be a valuable source of income. Explore ways to use skills for extra income and maximize your earning potential.
20,974 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Dell shares surged to a new all-time high after a blockbuster earnings report. This article breaks down the why, what...
A small-cap data services company sparked May’s AI rally, with Innodata surging nearly 150% after a solid earnings re...
A security audit uncovers a vulnerability in Trezor's secure element. While this raises questions about hardware wall...
As DocuSign navigates a changing digital transaction landscape, the docusign (DOCU) 2027 earnings thesis hinges on re...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
Chewy’s stock action in May left investors asking what happened and what comes next. This article breaks down the cat...
A Perdoceo director recently exercised 9,308 options and sold shares, triggering questions for investors. This guide ...
Mind tech (mind) 2027 is shaping a new era for investors who seek durable growth in neurotech and digital mental heal...
Arista Networks stock flew higher on Friday, climbing more than 4% on a fresh analyst upgrade. This article breaks do...
An insider at Rackspace Technology recently disclosed a significant stock sale. This article explains what that means...
The quantum computing sector has faced a pullback, but not every hire is a misfire. This article breaks down the rece...